Table 5

Principal indications for nuclear cardiology

Notes
Assessment of coronary artery disease, ischaemia and viability using myocardial perfusion scintigraphy/positron emission tomograph.
Assessment of left ventricular function in undergoing cardiotoxic cancer therapy (baseline and serial) where echocardiography is not appropriate using multigated acquisition/radionuclide ventriculography.
Investigating Infective endocarditis in special circumstances (eg, uncertainty-based around Duke criteria/indwelling medical devices).73ESC 201573
Myocardial inflammation (especially sarcoidosis) using positron emission tomography.
Transthyretin-type cardiac amyloidosis using bone scintigraphy (particularly with 99mTc-DPD).74ESC 201474
  • DPD, deoxypyridinoline; ESC, European Society of Cardiology.